Kathleen Laura Ruchalski

Title(s)HS Associate Clinical Professor, Radiological Sciences
SchoolMedicine
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. PSMA PET/CT Dual-Time-Point Imaging: Nice to Have or Need to Have? J Nucl Med. 2024 Jan 04. Unterrainer LM, Ruchalski K, Allen-Auerbach MS, Calais J, Benz MR. PMID: 38176724.
      View in: PubMed   Mentions:    Fields:    
    2. Carcinoid Heart Disease. Radiol Imaging Cancer. 2024 Jan; 6(1):e230164. Johnson S, Benz MR, Ruchalski K. PMID: 38276906; PMCID: PMC10825699.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Do Imaging Core Laboratories Better Predict Progression Over Clinical Interpretations? Radiol Imaging Cancer. 2023 09; 5(5):e230092. Margolis DJA, Ruchalski KL. PMID: 37540135; PMCID: PMC10546355.
      View in: PubMed   Mentions:    Fields:    
    4. RECIST 1.1 Target Lesion Categorical Response in Metastatic Renal Cell Carcinoma: A Comparison of Conventional versus Volumetric Assessment. Radiol Imaging Cancer. 2023 09; 5(5):e220166. Gong AJ, Ruchalski K, Kim HJ, Douek M, Gutierrez A, Patel M, Sai V, Coy H, Villegas B, Raman S, Goldin J. PMID: 37656041; PMCID: PMC10546365.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. Pretreatment visceral metastases in castration resistant metastatic prostate cancer: role in prediction versus actual site of disease progression. Cancer Imaging. 2022 Jul 14; 22(1):34. Ruchalski K, Kim HJ, Douek M, Raman S, Patel M, Sai V, Gutierrez A, Levine B, Fischer C, Allen-Auerbach M, Gupta P, Coy H, Villegas B, Brown M, Goldin J. PMID: 35836271; PMCID: PMC9281063.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    6. Imaging response assessment for oncology: An algorithmic approach. Eur J Radiol Open. 2022; 9:100426. Ruchalski K, Dewan R, Sai V, McIntosh LJ, Braschi-Amirfarzan M. PMID: 35693043; PMCID: PMC9184854.
      View in: PubMed   Mentions: 2  
    7. Automated Endotracheal Tube Placement Check Using Semantically Embedded Deep Neural Networks. Acad Radiol. 2022 May 26. Brown MS, Wong KP, Shrestha L, Wahi-Anwar M, Daly M, Foster G, Abtin F, Ruchalski KL, Goldin JG, Enzmann D. PMID: 35644754.
      View in: PubMed   Mentions: 4     Fields:    
    8. A Primer on RECIST 1.1 for Oncologic Imaging in Clinical Drug Trials. Radiol Imaging Cancer. 2021 05; 3(3):e210008. Ruchalski K, Braschi-Amirfarzan M, Douek M, Sai V, Gutierrez A, Dewan R, Goldin J. PMID: 33988475; PMCID: PMC8183261.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    9. Response criteria for intraocular retinoblastoma: RB-RECIST. Pediatr Blood Cancer. 2021 05; 68(5):e28964. Berry JL, Munier FL, Gallie BL, Polski A, Shah S, Shields CL, Gombos DS, Ruchalski K, Stathopoulos C, Shah R, Jubran R, Kim JW, Mruthyunjaya P, Marr BP, Wilson MW, Brennan RC, Chantada GL, Chintagumpala MM, Murphree AL. PMID: 33624399; PMCID: PMC8049511.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    10. Components of Radiologic Progressive Disease Defined by RECIST 1.1 in Patients with Metastatic Clear Cell Renal Cell Carcinoma. Radiology. 2019 07; 292(1):103-109. Coy HJ, Douek ML, Ruchalski K, Kim HJ, Gutierrez A, Patel M, Sai V, Margolis DJA, Kaplan A, Brown M, Goldin J, Raman SS. PMID: 31084479.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    11. Feasibility and Safety of Intrathoracic Biopsy and Repeat Biopsy for Evaluation of Programmed Cell Death Ligand-1 Expression for Immunotherapy in Non-Small Cell Lung Cancer. Radiology. 2018 04; 287(1):326-332. Tsai EB, Pomykala K, Ruchalski K, Genshaft S, Abtin F, Gutierrez A, Kim HJ, Li A, Adame C, Jalalian A, Wolf B, Garon EB, Goldman JW, Suh R. PMID: 29232184; PMCID: PMC6276060.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    12. Indeterminate Pulmonary Nodules: How to Minimize Harm. Semin Respir Crit Care Med. 2016 10; 37(5):689-707. Barjaktarevic I, Arenberg D, Grimes BS, Ruchalski K, Aberle DR. PMID: 27732991.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    13. Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma. N Engl J Med. 2016 Sep 01; 375(9):819-29. Zaretsky JM, Garcia-Diaz A, Shin DS, Escuin-Ordinas H, Hugo W, Hu-Lieskovan S, Torrejon DY, Abril-Rodriguez G, Sandoval S, Barthly L, Saco J, Homet Moreno B, Mezzadra R, Chmielowski B, Ruchalski K, Shintaku IP, Sanchez PJ, Puig-Saus C, Cherry G, Seja E, Kong X, Pang J, Berent-Maoz B, Comin-Anduix B, Graeber TG, Tumeh PC, Schumacher TN, Lo RS, Ribas A. PMID: 27433843; PMCID: PMC5007206.
      View in: PubMed   Mentions: 1420     Fields:    Translation:HumansCells
    14. Lung Cancer Screening Update. J Thorac Imaging. 2016 Jul; 31(4):190-200. Ruchalski KL, Brown K. PMID: 27306387.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansPHPublic Health
    15. Long term survival with cytotoxic T lymphocyte-associated antigen 4 blockade using tremelimumab. Eur J Cancer. 2015 Nov; 51(17):2689-97. Eroglu Z, Kim DW, Wang X, Camacho LH, Chmielowski B, Seja E, Villanueva A, Ruchalski K, Glaspy JA, Kim KB, Hwu WJ, Ribas A. PMID: 26364516; PMCID: PMC4821004.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    16. The evidence for low-dose CT screening of lung cancer. Clin Imaging. 2016 Mar-Apr; 40(2):288-95. Ruchalski K, Gutierrez A, Genshaft S, Abtin F, Suh R. PMID: 26362352.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    17. Tunable-combinatorial mechanisms of acquired resistance limit the efficacy of BRAF/MEK cotargeting but result in melanoma drug addiction. Cancer Cell. 2015 Feb 09; 27(2):240-56. Moriceau G, Hugo W, Hong A, Shi H, Kong X, Yu CC, Koya RC, Samatar AA, Khanlou N, Braun J, Ruchalski K, Seifert H, Larkin J, Dahlman KB, Johnson DB, Algazi A, Sosman JA, Ribas A, Lo RS. PMID: 25600339; PMCID: PMC4326539.
      View in: PubMed   Mentions: 173     Fields:    Translation:HumansCells
    18. A medley of midbrain maladies: a brief review of midbrain anatomy and syndromology for radiologists. Radiol Res Pract. 2012; 2012:258524. Ruchalski K, Hathout GM. PMID: 22693668; PMCID: PMC3366251.
      View in: PubMed   Mentions: 20  
    19. Hsp27 inhibits Bax activation and apoptosis via a phosphatidylinositol 3-kinase-dependent mechanism. J Biol Chem. 2008 May 02; 283(18):12305-13. Havasi A, Li Z, Wang Z, Martin JL, Botla V, Ruchalski K, Schwartz JH, Borkan SC. PMID: 18299320; PMCID: PMC2431006.
      View in: PubMed   Mentions: 83     Fields:    Translation:HumansAnimalsCells
    20. Distinct hsp70 domains mediate apoptosis-inducing factor release and nuclear accumulation. J Biol Chem. 2006 Mar 24; 281(12):7873-80. Ruchalski K, Mao H, Li Z, Wang Z, Gillers S, Wang Y, Mosser DD, Gabai V, Schwartz JH, Borkan SC. PMID: 16407317.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansAnimalsCells
    21. Lithium activates the Wnt and phosphatidylinositol 3-kinase Akt signaling pathways to promote cell survival in the absence of soluble survival factors. Am J Physiol Renal Physiol. 2005 Apr; 288(4):F703-13. Sinha D, Wang Z, Ruchalski KL, Levine JS, Krishnan S, Lieberthal W, Schwartz JH, Borkan SC. PMID: 15572521.
      View in: PubMed   Mentions: 59     Fields:    Translation:AnimalsCells
    22. Hsp72 interacts with paxillin and facilitates the reassembly of focal adhesions during recovery from ATP depletion. J Biol Chem. 2004 Apr 09; 279(15):15472-80. Mao H, Wang Y, Li Z, Ruchalski KL, Yu X, Schwartz JH, Borkan SC. PMID: 14718530.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimalsCells
    23. HSP72 inhibits apoptosis-inducing factor release in ATP-depleted renal epithelial cells. Am J Physiol Cell Physiol. 2003 Dec; 285(6):C1483-93. Ruchalski K, Mao H, Singh SK, Wang Y, Mosser DD, Li F, Schwartz JH, Borkan SC. PMID: 12930708.
      View in: PubMed   Mentions: 27     Fields:    Translation:AnimalsCells
    24. hsp72 inhibits focal adhesion kinase degradation in ATP-depleted renal epithelial cells. J Biol Chem. 2003 May 16; 278(20):18214-20. Mao H, Li F, Ruchalski K, Mosser DD, Schwartz JH, Wang Y, Borkan SC. PMID: 12611892.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimalsCells
    25. Heat stress prevents mitochondrial injury in ATP-depleted renal epithelial cells. Am J Physiol Cell Physiol. 2002 Sep; 283(3):C917-26. Li F, Mao HP, Ruchalski KL, Wang YH, Choy W, Schwartz JH, Borkan SC. PMID: 12176748.
      View in: PubMed   Mentions: 32     Fields:    Translation:AnimalsCells
    With one click, see people who:

    Run Clinical Trials

    See more options in the Advanced Search tab

    Kathleen's Networks
    Concepts (168)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (34)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCLA Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-3-g1ef1264b on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California